Ezrin (EZR) (C-Term) Peptide
Quick Overview for Ezrin (EZR) (C-Term) Peptide (ABIN8100123)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- EZR Peptide - C-terminal region
-
Sequence
- QESLQDEGAE PTGYSAELSS EGIRDDRNEE KRITEAEKNE RVQRQLLTLS
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- VIL2 Antibody (ARP97802_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Ezrin (EZR)
-
Background
-
Background Information: The cytoplasmic peripheral membrane protein encoded by this gene functions as a protein-tyrosine kinase substrate in microvilli. As a member of the ERM protein family, this protein serves as an intermediate between the plasma membrane and the actin cytoskeleton. This protein plays a key role in cell surface structure adhesion, migration and organization, and it has been implicated in various human cancers. A pseudogene located on chromosome 3 has been identified for this gene. Alternatively spliced variants have also been described for this gene.
Alternative Symbols: CVL, CVIL, VIL2, HEL-S-105
-
Molecular Weight
- 64 kDa
-
Gene ID
- 7430
-
NCBI Accession
- NP_001104547
-
UniProt
- P15311
Target
-
